Pay in 4 interest-free payments of $5.60 Learn more
Ships within 48 hours · Estimated delivery Nov 15 - Nov 20
The Precision Peptide Genetic Test maps 48 unique genes and 58 variants across 14 health pathways, returning 150+ genetic insights including 34 weight-management insights through the Peptide Pathways Report in the PlexusDx Results Portal
Michael Nauck: GLP-1 Origins | Ep
Tirzepatide is a first-in-class dual incretin receptor agonist a single molecule that activates both the GIP (glucose-dependent insulinotropic polypeptide) and the GLP-1 (glucagon-like peptide-1) receptors, which is why it is often nicknamed a twincretin. [7] By engaging two incretin pathways it enhances glucose-dependent insulin secretion, promotes satiety, and delays gastric emptying, producing large effects on both glycemic control and bodyweight
DSIP is not approved for human consumption, medical treatment, or therapeutic use in the United States
